Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis

Neuropharmacology

Volumn 51, Issue 5, 2006, Pages 1013-1022

  Kash, Thomas L ^a   Winder, Danny G ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anxiety; CRF; Electrophysiology; Extended amygdala; Neuropeptide Y; Whole cell

Indexed keywords

4 AMINOBUTYRIC ACID; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y2 RECEPTOR; UROCORTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GABAERGIC TRANSMISSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; INTRACELLULAR RECORDING; MALE; MOUSE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; REWARD; STRESS; STRIA TERMINALIS; SYNAPTIC INHIBITION; WHOLE CELL;

ANALYSIS OF VARIANCE; ANILINE COMPOUNDS; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPEPTIDE Y; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PYRIDAZINES; PYRIMIDINES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEPTAL NUCLEI; SYNAPTIC TRANSMISSION; UROCORTINS;

EID: 33749532648     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.06.011     Document Type: Article

References (47)

1. Acuna-Goycolea C., Tamamaki N., Yanagawa Y., Obata K., and van den Pol A.N. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J. Neurosci. 25 (2005) 7406-7419
2. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., and McCaleb M.L. Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 868 (2000) 79-87
3. Bremner J.D., Licinio J., Darnell A., Krystal J.H., Owens M.J., Southwick S.M., Nemeroff C.B., and Charney D.S. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psychiatry 154 (1997) 624-629
4. Campbell B.M., Morrison J.L., Walker E.L., and Merchant K.M. Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats. Pharmacol. Biochem. Behav. 77 (2004) 447-455
5. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., Murray S.E., Hill J.K., Pantely G.A., Hohimer A.R., Hatton D.C., Phillips T.J., Finn D.A., Low M.J., Rittenberg M.B., Stenzel P., and Stenzel-Poore M.P. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat. Genet. 24 (2000) 403-409
6. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., and Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24 (1999) 155-163
7. Cullinan W.E., Herman J.P., and Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J. Comp. Neurol. 332 (1993) 1-20
8. D'Este L., Casini A., Pontieri F.E., and Renda T.G. Changes in neuropeptide FF and NPY immunohistochemical patterns in rat brain under heroin treatment. Brain Res. 1083 (2006) 151-158
9. Dumont E.C., and Williams J.T. Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J. Neurosci. 24 (2004) 8198-8204
10. Dunn A.J., and Swiergiel A.H. Behavioral responses to stress are intact in CRF-deficient mice. Brain Res. 845 (1999) 14-20
11. Egli R.E., and Winder D.G. Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J. Neurophys 90 1 (2003) 405-414
12. Erb S., and Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J. Neurosci. 19 (1999) RC35
13. Erb S., Salmaso N., Rodaros D., and Stewart J. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl.) 158 (2001) 360-365
14. Georges F., and Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J. Neurosci. 22 (2002) 5173-5187
15. Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S.N., Berndt E.R., Davidson J.R., Ballenger J.C., and Fyer A.J. The economic burden of anxiety disorders in the 1990s. J. Clin. Psychiatry 60 (1999) 427-435
16. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul. Pept. 59 (1995) 201-205
17. Heilig M., Soderpalm B., Engel J.A., and Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl.) 98 (1989) 524-529
18. Heinrichs S.C., Lapsansky J., Lovenberg T.W., De Souza E.B., and Chalmers D.T. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul. Pept. 71 (1997) 15-21
19. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiatry 9 (2004) 984-997 979
20. Ju G., and Han Z.S. Coexistence of corticotropin releasing factor and neurotensin within oval nucleus neurons in the bed nuclei of the stria terminalis in the rat. Neurosci. Lett. 99 (1989) 246-250
21. Kask A., Rago L., and Harro J. Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats. Brain Res. 788 (1998) 345-348
22. Lee Y., and Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 17 (1997) 6434-6446
23. Lilly S.M., Zeng X.J., and Tietz E.I. Role of protein kinase A in GABAA receptor dysfunction in CA1 pyramidal cells following chronic benzodiazepine treatment. J. Neurochem. 85 (2003) 988-998
24. Ludwig M., and Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 7 (2006) 126-136
25. Nemeroff C.B. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol. Bull. 37 (2003) 133-146
26. Nicola S.M., and Malenka R.C. Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. J. Neurosci. 17 (1997) 5697-5710
27. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., and Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303 (2004) 1512-1514
28. Nusser Z., Sieghart W., and Mody I. Differential regulation of synaptic GABAA receptors by cAMP-dependent protein kinase in mouse cerebellar and olfactory bulb neurones. J. Physiol. 521 Pt 2 (1999) 421-435
29. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 72 (2002) 213-220
30. Parker R.M., and Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur. J. Neurosci. 11 (1999) 1431-1448
31. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Elsevier Academic Press, Amsterdam
32. Pronchuk N., Beck-Sickinger A.G., and Colmers W.F. Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 143 (2002) 535-543
33. Qian J., Colmers W.F., and Saggau P. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J. Neurosci. 17 (1997) 8169-8177
34. Redrobe J.P., Dumont Y., Herzog H., and Quirion R. Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav. Brain Res. 141 (2003) 251-255
35. Sahuque L.L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., Janak P.H., and Olive M.F. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl.) 186 (2006) 122-132
36. Sakanaka M., Shibasaki T., and Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 382 (1986) 213-238
37. Shekhar A., Truitt W., Rainnie D., and Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8 (2005) 209-219
38. Silva A.P., Carvalho A.P., Carvalho C.M., and Malva J.O. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44 (2003) 282-292
39. Sorensen G., Lindberg C., Wortwein G., Bolwig T.G., and Woldbye D.P. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. J. Neurosci. Res. 77 (2004) 723-729
40. Spencer S.J., Buller K.M., and Day T.A. Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. J. Comp. Neurol. 481 (2005) 363-376
41. Sun Q.Q., Akk G., Huguenard J.R., and Prince D.A. Differential regulation of GABA release and neuronal excitability mediated by neuropeptide Y1 and Y2 receptors in rat thalamic neurons. J. Physiol. 531 (2001) 81-94
42. Valdez G.R., and Koob G.F. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol. Biochem. Behav. 79 (2004) 671-689
43. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., and Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 428 (2000) 191-212
44. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur. J. Pharmacol. 463 (2003) 199-216
45. Walter A., Mai J.K., Lanta L., and Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J. Chem. Neuroanat. 4 (1991) 281-298
46. Yehuda R., Brand S., and Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol. Psychiatry 59 (2006) 660-663
47. Zhao H., Huang H.W., Wu G.C., and Cao X.D. Effect of orphanin FQ on interleukin-1beta mRNA transcripts in the rat CNS. Neuroscience 114 (2002) 1019-1031